RxDoctor Payments DataLook up a doctor →

Kyle Eberlin, MD

Plastic and Reconstructive Surgery · Boston, MANPI 1386844165

Payments from drug & device makers

$471,750in general payments, 2019–2025

Across 426 payments — averaging $1107.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$268K
  • Integra Lifesciences Corporation$110K
  • Checkpoint Surgical, Inc$29K
  • Sonex Health, Inc.$27K
  • Biocircuit Technologies Inc$16K
  • Medical Device Business Services, Inc.$14K
  • plus $9K from 15 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$471,750 in reported general payments places this provider in the 95th percentile of 67 plastic and reconstructive surgery providers in Massachusetts.

See all plastic and reconstructive surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$211,054
Medicare patients
284
Services billed
934

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →